Trial Profile
Effect of Food on the Pharmacokinetics of Anaplastic Lymphoma Kinase (Alk) Inhibitor Ceritinib 500mg in Healthy Subjects.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 02 Nov 2017
Price :
$35
*
At a glance
- Drugs Ceritinib (Primary)
- Indications Non-small cell lung cancer
- Focus Pharmacokinetics
- Sponsors Novartis Pharmaceuticals Corporation
- 10 Sep 2015 New trial record